USPTO Doubles Down Calling Out Pharmaceutical Industry - Patent
The justification was to provide examiners and judges with all the material information needed to decide on patentability of a claimed invention.
Katherine Vidal Trademark Office Goodwin Life Sciences Drug Administration Patent Trial Appeal Board
Source: mondaq.com